MedPlus Health Services Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26 to BSE Limited and the National Stock Exchange of India Limited, in compliance with Regulation 34(2)(f) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report, filed on July 23, 2026, by Company Secretary and Compliance Officer Shrenik Soni, forms part of the company's Annual Report for FY 2025-26 and is available on the company's website at www.medplusindia.com , as well as on the BSE and NSE portals.

Company Overview and Operations

MedPlus Health Services Limited, registered under CIN No. L85110TG2006PLC051845 and headquartered in Hyderabad, Telangana, operates as one of India's largest retail pharmacy chains. Approximately 90% of its operations are conducted through its subsidiary, Optival Health Solutions Private Limited (OHSPL), which has accordingly been included within the reporting boundary. The company serves end-use consumers of pharmaceutical and fast-moving consumer goods across 14 states in India, with no international operations.

The following table summarises the company's operational footprint as disclosed in the BRSR:

Workforce and Employee Welfare

As at the end of FY 2025-26, MedPlus reported a total permanent employee count of 27,686, with females constituting 31.76% of the workforce. The company does not employ permanent workers, and no differently abled employees or workers were reported during the period. Key workforce metrics are presented below:

The Board of Directors comprises 6 members, of whom 1 (16.67%) is female. Key Managerial Personnel number 4, with no female representation. Regarding remuneration, the median annual salary for Directors stands at ₹10,50,000 for males and ₹10,00,000 for females, while Key Managerial Personnel receive a median annual remuneration of ₹73,02,562 for males.

On employee benefits, 100% of permanent employees are covered under health insurance and accident insurance. Maternity benefit coverage stands at 14.09% of total permanent employees (3,900 individuals), while day care facility coverage is reported for 5,252 male employees and 2,764 female employees. Additionally, 22,436 employees are covered under ESI out of a total of 25,007 employees in applicable categories.

During the reporting year, 47.40% of employees received training, with the company noting that the remaining 52.60% were trained in the previous year, resulting in 100% cumulative training coverage inclusive of new joiners and refresher courses. Directors and Key Managerial Personnel each received 3 training and awareness programmes, achieving 100% coverage in their respective categories.

Financial and Governance Disclosures

The BRSR discloses the following standalone financial parameters for the reporting period:

The company's standalone turnover figure was referenced but not fully disclosed in the filing. MedPlus's governance framework encompasses policies aligned with all nine National Guidelines on Responsible Business Conduct (NGRBC) principles, all of which have been approved by the Board. Policy reviews are conducted annually for performance-related matters and quarterly for compliance-related matters. No external agency has been engaged for independent assessment of Business Responsibility and Sustainability policies; oversight is maintained through internal audits, management reviews, and Board committee oversight.

The company has an Anti-Corruption and Anti-Bribery Policy in place, explicitly forbidding abusive, corrupt, and anti-competitive practices. No fines, penalties, or non-monetary sanctions were reported during the year across any NGRBC principle.

Environmental Stewardship

MedPlus has outlined several environmental initiatives as part of its sustainability commitments. The company is in the process of replacing all lighting with energy-efficient alternatives and continuously monitors energy consumption across its network. Key waste management and environmental practices include:

• Plastic waste: Recycled through third-party service providers
• E-waste: Recycled through third-party service providers
• Hazardous waste: Managed through authorized third-party specialists
• Non-hazardous waste: Sent to third-party providers for recycling
• Supply chain: Streamlined from central warehouses to retail outlets to reduce fuel use
• Packaging: Transitioning from single-use plastic bags to compostable bags in stores; recyclable plastic bags, reusable plastic crates, and biodegradable covers used in warehouses

The company has not conducted any Life Cycle Assessments (LCA) for its services during the reporting period. No Zero Liquid Discharge mechanism has been implemented. The Global Warming Potential (GWP) factor of AR5 with a value of 21 has been used for GHG emissions calculations. No Green Credits were generated or procured by the entity or its top ten value chain partners during the period.

Stakeholder Engagement and CSR

MedPlus engages with multiple stakeholder groups—including patients and customers, employees, suppliers, channel partners, government and regulators, shareholders, and communities—through regular communication channels such as retail pharmacy interactions, social media, HR management systems, business reviews, shareholder meetings, and CSR initiatives. A comprehensive materiality assessment involving all stakeholder groups was conducted to identify material ESG issues.

The company's CSR programme during FY 2025-26 covered 15 projects, all of which directed 100% of beneficiaries from vulnerable and marginalized groups. Notable CSR projects included the Sir C.V. Raman Akshaya Science Centre (250 beneficiaries), the Student Mobility Support Programme (97 beneficiaries), Solar Panels for farmers in Adilabad district (100 beneficiaries), and an Ambulance project (1,000 beneficiaries), among others.

Consumer Responsibility and Data Privacy

MedPlus operates a Customer Relationship Management (CRM) platform to receive and track consumer complaints and feedback. The company reported zero voluntary and zero forced product recalls during the reporting period, and zero data breach instances. Its privacy policy is accessible at https://www.medplusindia.com/privacy-policy.jsp . Product information disclosures—covering environmental and social parameters, safe and responsible usage, and recycling or safe disposal—are provided on 100% of products as a percentage of total turnover. The company's online product and services platform is accessible at https://www.medplusmart.com .

MedPlus Health Services has scheduled its 20th Annual General Meeting (AGM) for Monday, August 17, 2026, to approve critical board appointments and financial resolutions. The meeting, conducted via Video Conferencing (VC) or Other Audio-Visual Means (OAVM), will see shareholders vote on the re-appointment of Managing Director & CEO Gangadi Madhukar Reddy for a five-year term, alongside the induction of two new independent directors. This governance update follows the company’s filing of its FY26 Annual Report, which reported a consolidated revenue of ₹68,924.66 million and a profit after tax of ₹2,196.06 million.

The AGM agenda includes ordinary business items such as the adoption of audited standalone and consolidated financial statements for the year ended March 31, 2026. Dr. Cherukupalli Bhaskar Reddy, Whole Time Director, retires by rotation and seeks re-appointment. Shareholders holding shares as of the cut-off date, August 10, 2026, are eligible to participate in remote e-voting, which opens on August 14, 2026, at 09:00 AM IST and closes on August 16, 2026, at 05:00 PM IST.

Key Resolutions and Board Appointments

The special business section of the AGM focuses on strengthening the board’s composition with diverse expertise. The Nomination and Remuneration Committee recommended the appointment of Mr. Mohan Krishna Reddy and Mr. Ajit Pandurang Rangnekar as Independent Directors. Both appointments require special resolutions under Regulation 17(1A) of the SEBI LODR Regulations due to their age exceeding or approaching 75 years.

Mr. Mohan Krishna Reddy brings over three decades of experience in finance and strategy, including roles at Indian Bank, Unit Trust of India, and JM Financial. Mr. Ajit Pandurang Rangnekar offers more than 50 years of leadership experience across manufacturing, services, and consulting sectors, including a B.Tech from IIT Bombay and a PGP from IIM Ahmedabad.

Re-appointment of Managing Director & CEO

Shareholders will also vote on the re-appointment of Gangadi Madhukar Reddy as Managing Director & CEO for a period of five years, commencing August 03, 2026, and ending August 02, 2031. His consolidated remuneration is capped at ₹4.00 million per annum, subject to limits prescribed under the Companies Act, 2013. In the event of inadequate profits, his remuneration will adhere to Schedule V of the Act. Mr. Reddy, who holds an MBA from Wharton School, has been instrumental in driving the company’s expansion to over 5,330 stores across 13 states and one union territory.

Auditor Ratification and Governance

The AGM will also ratify the remuneration of M/s. M P R & Associates, Cost Accountants, as Cost Auditors for FY27. The approved fee is ₹1,50,000 plus applicable taxes and out-of-pocket expenses. The Statutory Auditors for FY26 were M/s. B S R and Co., which issued an unqualified audit report. The Secretarial Audit by M/s. R & A Associates contained no qualifications.

E-Voting and Meeting Logistics

KFin Technologies Limited serves as the Registrar and Transfer Agent and e-voting service provider. Members can cast votes via remote e-voting using credentials linked to their demat accounts or physical folios. The facility for attending the AGM virtually is available on a first-come, first-served basis for up to 1,000 members, excluding large shareholders, promoters, and institutional investors. Questions from members must be submitted at least 72 hours before the AGM via the designated email IDs or the e-voting portal.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE804L01022/998fd76c-9619-414c-9115-3279df5d440e.pdf